Updating results

7 results

Sort: Relevance | Date

Larotrectinib for treating advanced solid tumours with TRK fusions [ID1299]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 07 February 2020.

Technology appraisal guidance In consultation

Liraglutide for managing overweight and obesity [ID740]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 14 February 2020.

Technology appraisal guidance In consultation

Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer [ID1504]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 28 January 2020.

Technology appraisal guidance In consultation

Ustekinumab for treating moderately to severely active ulcerative colitis [ID1511]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 11 February 2020.

Technology appraisal guidance In consultation

Gilteritinib for treating relapsed or refractory acute myeloid leukaemia [ID1484]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 05 February 2020.

Technology appraisal guidance In consultation

Pembrolizumab for untreated metastatic or unresectable recurrent squamous cell head and neck cancer [ID1140]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 05 February 2020.

Technology appraisal guidance In consultation

Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant [ID1508]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 04 February 2020.

Technology appraisal guidance In consultation